CLINICAL_TRIALS
trial_result
· 2015-11-16
Clinical Trial Update: Pharmacokinetic and Safety Study of Daclatasvir in Patients With Renal Impairment [Phase 1]
Summary
Phase 1 pharmacokinetic and safety study evaluating daclatasvir in patients with renal impairment to assess drug exposure and tolerability.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED | Results posted: 2015-11-16